biotech · Chronic Hepatitis b · Hepatitis B, Chronic · ABUS
Arbutus Biopharma
Arbutus Biopharma Corp
Arbutus Biopharma clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 701 Veterans Circle, Warminster, Pennsylvania 18974, US
- Employees
- 49
- Programs
- 13
- Drugs
- 7
- Patents
- 56
Arbutus Biopharma projects
13 ClinicalTrials.gov programs sponsored by Arbutus Biopharma.
Arbutus Biopharma has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AB-729
Arbutus Biopharma Corp
Chronic Hepatitis b
1 trial -
AB-729-203
Arbutus Biopharma Corp
Chronic HBV Infection
1 trial -
ARB-001467
Arbutus Biopharma Corp
Hepatitis B, Chronic
1 trial -
Imdusiran
Arbutus Biopharma Corp
Hepatitis B, Chronic
1 trial -
Imdusiran (AB-729)
Arbutus Biopharma Corp
Chronic Hepatitis B
1 trial -
TKM-080301
Arbutus Biopharma Corp
Hepatocellular Carcinoma
1 trial -
TKM-080301
Arbutus Biopharma Corp
Cancer
1 trial -
AB-101
Arbutus Biopharma Corp
Chronic Hepatitis b
1 trial -
AB-101-001
Arbutus Biopharma Corp
Chronic hepatitis B virus Infection
1 trial -
AB-836
Arbutus Biopharma Corp
Chronic Hepatitis
1 trial -
PRO-040201
Arbutus Biopharma Corp
Hypercholesterolemia
1 trial -
TKM-100201
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial -
TKM-100802 for Injection
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial
Frequently asked questions
How many clinical projects does Arbutus Biopharma have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.